Drug reference

Fibrinogen, dried

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 143

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

Cardiovascular system Treatment of haemorrhage in congenital hypofibrinogenaemia or afibrinogenaemia ▶BY INTRAVENOUS INJECTION, OR BY INTRAVENOUS INFUSION ▶Adult: (consult haematologist)

PDF page 143

Cautions

Risk of thrombosis. vaccination against hepatitis A and hepatitis B may be required

PDF page 143

Prescribing And Dispensing Information

Fibrinogen is prepared from human plasma.

PDF page 143

Safety

Side Effects

▶Common or very common Fever. thromboembolism ▶Frequency not known Chest pain. chills. cough. dyspnoea. nausea. skin reactions. tachycardia. vomiting

PDF page 143

Pregnancy

Manufacturer advises not known to be harmful—no information available.

PDF page 143

Breast Feeding

Manufacturer advises avoid—no information available.

PDF page 143

Dose and formulations

Medicinal Forms

There can be variation in the licensing of different medicines containing the same drug. Powder for solution for infusion ▶Riastap (CSL Behring UK Ltd) Fibrinogen 1 gram Riastap 1g powder for solution for infusion vials | 1 vial P £400.00

PDF page 143

Dose text by age group

Adult

(consult haematologist)

First-line fragment. Read the complete Indications and Dose section above.

PDF page 143

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

Fibrinogen, dried

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 143

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

Cardiovascular system Treatment of haemorrhage in congenital hypofibrinogenaemia or afibrinogenaemia ▶BY INTRAVENOUS INJECTION, OR BY INTRAVENOUS INFUSION ▶Adult: (consult haematologist)

PDF page 143

Cautions

Risk of thrombosis. vaccination against hepatitis A and hepatitis B may be required

PDF page 143

Prescribing And Dispensing Information

Fibrinogen is prepared from human plasma.

PDF page 143

Safety

Side Effects

▶Common or very common Fever. thromboembolism ▶Frequency not known Chest pain. chills. cough. dyspnoea. nausea. skin reactions. tachycardia. vomiting

PDF page 143

Pregnancy

Manufacturer advises not known to be harmful—no information available.

PDF page 143

Breast Feeding

Manufacturer advises avoid—no information available.

PDF page 143

Dose and formulations

Medicinal Forms

PDF page 143

Dose text by age group

Adult

(consult haematologist)

First-line fragment. Read the complete Indications and Dose section above.

PDF page 143

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.